SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,446.08 |
| Enterprise Value ($M) | 2,261.00 |
| Book Value ($M) | 500.76 |
| Book Value / Share | 5.24 |
| Price / Book | 4.88 |
| NCAV ($M) | 483.52 |
| NCAV / Share | 5.06 |
| Price / NCAV | 5.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.35 |
| Return on Equity (ROE) | -0.38 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.58 |
| Current Ratio | 7.58 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 611.31 |
| Assets | 628.55 |
| Liabilities | 127.79 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 9.56 |
| Operating Income | -235.60 |
| Net Income | -212.22 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -119.06 |
| Cash from Investing | -130.07 |
| Cash from Financing | 93.86 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 12.10 | 39.59 | |
| 13D/A | Rtw Investments, Lp | 44.14 | ||
| 13G/A | Ra Capital Management, L.p. | 3.30 | -55.00 | |
| 13G/A | Vanguard Group Inc | 5.46 | 16.50 | |
| 13G/A | Fmr Llc | 14.04 | -2.06 | |
| 13G/A | Cowen Financial Products LLC | 7.60 | 8.48 | |
| 13G/A | BlackRock Inc. | 8.80 | 22.90 | |
| 13G/A | State Street Corp | 4.64 | -3.69 | |
| 13G | Bristol Myers Squibb Co | 6.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 150,844 | 641,653 | 23.51 | |
| 95,289 | 250,210 | 38.08 | |
| 189,770 | 493,901 | 38.42 | |
| 149,121 | 442,617 | 33.69 | |
| 98,283 | 227,157 | 43.27 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RAPT – RAPT Therapeutics, Inc. | RCKT – Rocket Pharmaceuticals, Inc. |
| RLAY – Relay Therapeutics, Inc. | RNAC – Cartesian Therapeutics, Inc. |
| RPHM – Reneo Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io